Rytary ER 48.75 MG-195 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB26FABE2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,345
Award facts
- Contract value 100% obligated
- $11,344.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Rytary ER 48.75 mg-195 mg capsules (100-count units) with a ceiling value of $11,344.59. This firm fixed-price delivery order is non-set-aside and utilizes competitive procurement procedures. The contract is performed at the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by November 4, 2025. This award represents a single delivery order executed under a larger contract vehicle supporting the DLA's pharmaceutical supply chain.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant Indefinite Delivery Contract (SPE2DX) with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle for this delivery order. The prime contract enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. Rytary ER is a carbidopa-levodopa extended-release medication used in Parkinson's disease management, reflecting the breadth of neurological treatments the contractor supplies through federal medical procurement programs serving the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB26FABE2?
SPE2DB26FABE2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FABE2 worth?
The government has obligated $11,345 on SPE2DB26FABE2.
Is contract SPE2DB26FABE2 an order under another contract?
Yes. SPE2DB26FABE2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABE2 competed?
The extent of competition for SPE2DB26FABE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award